Heart rate variability in patients with psoriatic arthritis: associations with systemic inflammation and traditional cardiovascular risk factors
https://doi.org/10.15829/1728-8800-2011-2-88-92
Abstract
Aim. To identify the disturbances of vegetative heart regulation and their associations with systemic inflammation activity in patients with psoriatic arthritic (PsA).
Material and methods. The main group (MG) included 32 PsA patients without cardiovascular disease, CVD (mean age 44,62±11,6 years; mean PsA duration 10,32±10,2 years; 52,3% men). The control group (CG) included 25 healthy volunteers (mean age 40,33±11,8 years; 49,1% men). Time and spectral parameters of heart rate variability (HRV) were assessed. PsA activity was assessed by DAS index, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and fibrinogen (FG) levels. Cardiovascular risk (CVR) was calculated, based on the following parameters: lipid spectr arterial hypertension, body mass index, and family history of CVD.
Results. Compared to CG, all HRV parameters were affected in MG patients (p<0,01). HRV parameters were associated with PsA activity (ESR, CRP, FG, enthesitis), as well as with CVD risk factors (dyslipidemia, age).
Conclusion. In PsA patients, disturbed vegetative heart regulation was manifested in reduced HRV and activated sympathetic HRV component. These disturbances were associated with traditional CVD risk factors and systemic inflammation activity.
About the Authors
I. Z. Gaydukova
V.I. Razumovsky Saratov State Medical University
Russian Federation
Saratov
Russian Federation
Saratov
D. A. Poddubnyi
V.I. Razumovsky Saratov State Medical University
Russian Federation
Saratov
Russian Federation
Saratov
A. P. Rebrov
V.I. Razumovsky Saratov State Medical University
Russian Federation
Saratov
Russian Federation
Saratov
References
1. Псориатический артрит. В кн.: Клинические рекомендации. Ревматология. Под ред. Е.Л. Насонова. ГЕОТАРМедиа 2005; 92-8.
2. Gladman DD, Farewell VT, Wong K. Mortality studies in psoriatic arthritis: results from a single outpatient center. Prognostic indicators for death. Arthritis Rheum 1998; 41: 1103-10.
3. Divecha H, Sattar N, Rumley A, et al. Cardiovascular risk parameters in men with ankylosing spondylitis in comparison with non-inflammatory control subjects: relevance of systemic inflammation. Clin Sci (Lond.) 2005; 109: 171-6.
4. Sajadieh A, Nielsen OW, Rasmussen V, et al. Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease. Eur Heart J 2004; 25: 363-70.
5. Sloan RP, McCreath H, Tracey KJ, et al. RR interval variability is inversely related to inflammatory markers: the CARDIA study. J Mol Med 2007; 13: 178-84.
6. Madsen T, Christensen JH, Toft E, Schmidt EB. C-reactive protein is associated with heart rate variability. Ann Noninvas Electrocardiol 2007; 12: 216-22.
7. Lampert R, Bremner JD, Su S, et al. Decreased heart rate variability is associated with higher levels of inflammation in middle-aged men. Am Heart J 2008; 156: 759, e751-7.
8. Tsuji H, Larson MG, Venditti FJ, et al. Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation 1996; 94: 2850-5.
9. De Bruyne MC, Kors JA, Hoes AW, et al. Both decreased and increased heart rate variability on the standard 10-second electrocardiogram predict cardiac mortality in the elderly: the Rotterdam Study. Am J Epidemiol 1999; 150: 1282-8.
10. Dekker JM, Crow RS, Folsom AR, et al. Low heart rate variability in a 2-minute rhythm strip predicts risk of coronary heart disease and mortality from several causes: the ARIC Study. Atherosclerosis Risk In Communities. Circulation 2000; 102: 1239-44.
11. Sajadieh A, Nielsen OW, Rasmussen V, et al. C-reactive protein, heart rate variability and prognosis in community subjects with no apparent heart disease. J Intern Med 2006; 260: 377-87.
12. Новикова Д.С., Коротаева Т.В., Логинова Е.Ю. и др. Клиническое значение оценки вариабельности ритма сердца у больных псориатическим артритом. Тер архив 2009; 6: 47-52.
13. Neiman AL, Shin DB, Wang X et al. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatology 2006; 55: 829-35.
14. Бадокин В.В., Янышева А.В., Александрова Е.Н. и др. Риск развития сердечно-сосудистых заболеваний при псориатическом артрите. Тер архив 2009; 6: 41-7.
15. Jones SM, Harris CPD, Lloyd J, et al. Lipoproteins and their subfractions in psoriatic arthritis: identification of an atherogenic profile with active joint disease. Ann Rheum Dis 2000; 59 (5): 904-9.
16. Han C, Robinson DW, Hackett MV, et al. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 2006, 33: 2167-72.
17. Gisondi P, Tessari G, Conti A, et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based casecontrol study. Br J Dermatol 2007; 157 (1): 68-73.
18. Парнес Е.Я, Красносельский М.Я., Цурко В.В. и др. Долгосрочный прогноз у больных ревматоидным артритом в зависимости от исходной вариабельности сердечного ритма. Тер архив 2005; 9: 77-80.
Review
For citations:
Gaydukova I.Z., Poddubnyi D.A., Rebrov A.P. Heart rate variability in patients with psoriatic arthritis: associations with systemic inflammation and traditional cardiovascular risk factors. Cardiovascular Therapy and Prevention. 2011;10(2):88-92. (In Russ.) https://doi.org/10.15829/1728-8800-2011-2-88-92
Views:
655
Email this article 
